0
Abstract: Poster Presentations |

FATIGUE OF INSPIRATORY RESPIRATORY MUSCULATURE IN PATIENTS WITH COPD AND POTENTIAL METHODS FOR REVERSAL FREE TO VIEW

Nodira I. Zoirova, MD, PhD*
Author and Funding Information

Scientific Research Institute of Rehabilitation, Tashkent, Uzbekistan



Chest. 2006;130(4_MeetingAbstracts):246S. doi:10.1378/chest.130.4_MeetingAbstracts.246S-c
Text Size: A A A
Published online

Abstract

PURPOSE: To conduct a comparative evaluation of the efficacy of percutaneous electrostimulation of the diaphragm versus pharmacologic treatment with etimyzole for improving inspiratory respiratory muscular function in patients with COPD.

METHODS: 58 patients with COPD were enrolled in this study. The reversibility of obstruction was established through pre- and post-beta agonist (salbutamol, berotek) pulmonary function testing. Post-beta agonist testing was performed 20 minutes after inhalation. An increase in flow indicators of lung capacity and expiration velocity per 1 sec. of 12% or more was considered as a reliable indicator of reversibility. Diaphragm fatigue was calculated by the discriminate equation: F=17.3 × FEF50. Diaphragm fatigue was diagnosed based on F<65.1. All patients who met criteria for diaphragm fatigue received standard therapy for COPD. Patients were randomly assigned for treatment with either daily electrostimulation of the diaphragm for 6-8 days (28 patients) or treatment with etimyzole in a dose of 100 mg p.o. 3-4 times per day after meals for 10-20 days(30 patients).

RESULTS: Patients in this study who were randomized to treatment with etimyzole demonstrated greater improvement in inspiratory muscular function than the patients who received electrostimulation treatment.

CONCLUSION: Medical therapy with etimyzole may be successfully used in the treatment of patients with COPD and fatigue of inspiratory respiratory musculature. Etimyzole appears to be superior to electrical stimulation of the diaphragm for improving respiratory function.

CLINICAL IMPLICATIONS: Etimyzole therapy may have a role in reducing inspiratory musculature fatigue in patients with COPD. Further testing is needed to establish the long-term efficacy and also to establish a potential benefit of etimyzole treatment used in combination with electrical stimulation therapy.

DISCLOSURE: Nodira Zoirova, None.

Wednesday, October 25, 2006

12:30 PM - 2:00 PM


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543